Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Regulatory News (CLL)

  • There is currently no data for CLL

Digital capability widened

8 May 2009 14:55

RNS Number : 9610R
Cello Group plc
08 May 2009
 



8 May 2009

Cello Group plc

Digital capability widened with increased holding in Face Group

 

Cello Group plc ("Cello" or the "Group", AIM: CLL), the leading independent market research and consulting group, has acquired an additional 30.6% in Fenix Media Limited ("Fenix Media"), taking its total holding to 50.7%. The original stake was acquired in December 2007. 

Fenix Media trades under the name Face Group (http://www.facegroup.co.uk) and has a number of leading edge digital research and co-creation products.

Mark Scott, Cello Chief Executive, commented:

"Taking a majority stake in Face Group is another important step in widening our digital capabilities. The products and services offered by Face Group are increasingly in demand from our growing range of global blue chip client base."

The Group will issue 443,792 new ordinary shares of 10p each ("Ordinary Shares") pursuant to the share purchase agreement with the vendors of Fenix Media. Application has been made for the Ordinary Shares to be admitted to trading on AIM and admission is expected to occur on 13 May 2009. The Ordinary Shares are subject to a full trading lock-in for a year and a sliding lock-in for the following two years. 

The Group has now settled all of the earn out and related liabilities that were detailed in the results announcement of 17 March 2009 as being due for settlement within one year. 

The Group's issued share capital, following this issue of 443,792 new ordinary shares will be 58,762,197 Ordinary Shares. The new Ordinary Shares will rank from admission pari passu in all respects with the existing Ordinary Shares in issue. The Group holds 237,000 Ordinary Shares in treasury at the date of this announcement. The total number of current voting rights in the Group will therefore be 58,525,197 shares.

The above figure (58,525,197 Ordinary Shares) may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the Group under the FSA's Disclosure and Transparency Rules. 

Enquiries

 

Cello Group 

 

Mark Scott, Chief Executive

020 7812 8460

Mark Bentley, Finance Director

 

Singer Capital Markets

 

Nicholas How

020 3205 7620

 

 

College Hill

 

Adrian Duffield/Rozi Morris

020 7457 2020

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUWVORKORVRAR
Date   Source Headline
2nd Oct 20198:40 amRNSDisposal
18th Sep 20197:00 amRNSInterim Results
23rd Aug 201910:40 amRNSHolding(s) in Company
16th Aug 20197:00 amRNSAcquisition of ISS
6th Aug 20193:07 pmRNSTotal Voting Rights
6th Aug 20197:00 amRNSNotification of Half Year Results
18th Jul 20197:00 amRNSPre-close Trading Update
20th Jun 20194:29 pmRNSDirector/PDMR Shareholding
10th Jun 20199:41 amRNSTotal Voting Rights
24th May 201912:45 pmRNSBlock listing Interim Review
20th May 20194:29 pmRNSIssue of Equity
15th May 20197:00 amRNSHolding(s) in Company
8th May 20191:30 pmRNSResult of AGM
8th May 20197:00 amRNSAGM Statement
1st May 201912:15 pmRNSTotal Voting Rights
15th Apr 201911:12 amRNSAnnual Report and Notice of AGM
10th Apr 20197:00 amRNSCapital Markets Event
4th Apr 201910:00 amRNSTotal Voting Rights
27th Mar 20191:00 pmRNSHolding(s) in Company
21st Mar 20193:10 pmRNSDirector/PDMR Shareholding
21st Mar 20197:00 amRNSPreliminary Results
6th Mar 20191:51 pmRNSHolding(s) in Company
7th Feb 20197:00 amRNSNotice of Full Year Results
17th Jan 20197:00 amRNSPre-Close Trading Statement
14th Dec 20189:24 amRNSBlock Listing Update
23rd Nov 20183:45 pmRNSHolding(s) in Company
19th Nov 20182:45 pmRNSHolding(s) in Company
12th Nov 201811:30 amRNSDirectorate Change
5th Nov 20182:00 pmRNSDirectorate Change
31st Oct 20183:30 pmRNSDirector/PDMR Shareholding
10th Oct 20187:00 amRNSDirector/PDMR Shareholding
2nd Oct 20187:00 amRNSAppointment of Executive Director
25th Sep 20181:00 pmRNSDirector/PDMR Shareholding
25th Sep 20187:00 amRNSDirector/PDMR Shareholding
24th Sep 201811:39 amRNSTransfer of FTSE classification to Healthcare
21st Sep 201810:15 amRNSDirector/PDMR Shareholding
20th Sep 20184:00 pmRNSHolding(s) in Company
20th Sep 20187:00 amRNSDirector/PDMR Shareholding
19th Sep 20187:00 amRNSInterim Results
22nd Aug 20181:51 pmRNSHolding(s) in Company
17th Aug 20187:00 amRNSNotification of Half Year Results
16th Aug 20182:00 pmRNSTotal Voting Rights
16th Aug 20181:30 pmRNSBoard Changes
23rd Jul 20187:00 amRNSHolding(s) in Company
19th Jul 20187:00 amRNSPre-close Trading Update
17th Jul 20187:00 amRNSChange of registered office
4th Jul 20181:53 pmRNSHolding(s) in Company
27th Jun 201812:46 pmRNSHolding(s) in Company
22nd Jun 20184:47 pmRNSHolding(s) in Company
20th Jun 20182:25 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.